Immediate breast reconstruction does not lead to a delay in the delivery of adjuvant chemotherapy

Eur J Surg Oncol. 2004 Aug;30(6):624-7. doi: 10.1016/j.ejso.2004.04.006.

Abstract

Immediate breast reconstruction (IBR) has been considered by some to lead to a delay in the delivery of adjuvant chemotherapy. Our aim was to determine whether IBR led to a delay when compared to conservation surgery and non-reconstructive mastectomy. Ninety-five cases of IBR receiving chemotherapy were reviewed. These were compared to 95 consecutively treated patients undergoing conservation surgery and 95 undergoing non-reconstructive mastectomy. Our data shows that IBR does not lead to a delay in the delivery of adjuvant chemotherapy when compared to standard non-reconstructive surgery and should not adversely affect breast cancer outcome.

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / surgery*
  • Chemotherapy, Adjuvant / methods
  • Cohort Studies
  • Female
  • Humans
  • Mammaplasty / methods*
  • Mastectomy / methods
  • Time Factors

Substances

  • Antineoplastic Agents